This week in gene and cell therapy - 17 May 2019

Gene and cell therapy headlines 13 May - 17 May

Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients

Clinical Trial Underway for a Natural Killer Cell Therapy

SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation

European Commission kills billion-euro flagship concept

First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation